These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 1993014

  • 1. Chemotherapy for oligodendroglioma. Progress report.
    Cairncross JG, Macdonald DR.
    Arch Neurol; 1991 Feb; 48(2):225-7. PubMed ID: 1993014
    [No Abstract] [Full Text] [Related]

  • 2. Successful chemotherapy for newly diagnosed aggressive oligodendroglioma.
    Macdonald DR, Gaspar LE, Cairncross JG.
    Ann Neurol; 1990 May; 27(5):573-4. PubMed ID: 2360797
    [Abstract] [Full Text] [Related]

  • 3. Intensified PCV-chemotherapy with optional stem cell support in recurrent malignant oligodendroglioma.
    Zander T, Nettekoven W, Kraus JA, Pels H, Ko YD, Vetter H, Klockgether T, Schlegel U.
    J Neurol; 2002 Aug; 249(8):1055-7. PubMed ID: 12195453
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The molecular genetics of oligodendroglioma].
    Teng LH, Gui QP, Xuan Q, Lu DH.
    Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):471-3. PubMed ID: 15498225
    [No Abstract] [Full Text] [Related]

  • 6. Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities.
    Buckner JC, Gesme D, O'Fallon JR, Hammack JE, Stafford S, Brown PD, Hawkins R, Scheithauer BW, Erickson BJ, Levitt R, Shaw EG, Jenkins R.
    J Clin Oncol; 2003 Jan 15; 21(2):251-5. PubMed ID: 12525516
    [Abstract] [Full Text] [Related]

  • 7. Aggressive oligodendroglioma: a chemosensitive tumor.
    Cairncross JG.
    Recent Results Cancer Res; 1994 Jan 15; 135():127-33. PubMed ID: 8047688
    [No Abstract] [Full Text] [Related]

  • 8. [Assessment of procarbazine, vincristine and lomustine association (PCV protocol) in oligodendroglioma and mixed glioma].
    Bouffet E, Mornex F, Jouvet A, Thiesse P, Mertens P, Helfre S, Sindou M, Bret P.
    Bull Cancer; 1997 Oct 15; 84(10):951-6. PubMed ID: 9435796
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. PCV chemotherapy for oligodendroglioma: response analyzed on T2 weighted-MRI.
    Diabira S, Rousselet MC, Gamelin E, Soulier P, Jadaud E, Menei P.
    J Neurooncol; 2001 Oct 15; 55(1):45-50. PubMed ID: 11804282
    [Abstract] [Full Text] [Related]

  • 11. Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.
    Stege EM, Kros JM, de Bruin HG, Enting RH, van Heuvel I, Looijenga LH, van der Rijt CD, Smitt PA, van den Bent MJ.
    Cancer; 2005 Feb 15; 103(4):802-9. PubMed ID: 15637687
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
    Soffietti R, Nobile M, Rudà R, Borgognone M, Costanza A, Laguzzi E, Mutani R.
    Cancer; 2004 Feb 15; 100(4):807-13. PubMed ID: 14770438
    [Abstract] [Full Text] [Related]

  • 16. Semi-quantification of methionine uptake and flair signal for the evaluation of chemotherapy in low-grade oligodendroglioma.
    Tang BN, Sadeghi N, Branle F, De Witte O, Wikler D, Goldman S.
    J Neurooncol; 2005 Jan 15; 71(2):161-8. PubMed ID: 15690133
    [Abstract] [Full Text] [Related]

  • 17. Response and control: lessons from oligodendroglioma.
    Cairncross JG, Eisenhauer EA.
    J Clin Oncol; 1995 Sep 15; 13(9):2475-6. PubMed ID: 7666112
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dramatic response to chemotherapy in oligodendroglial gliomatosis cerebri.
    Schiff D.
    Neurology; 2003 Aug 12; 61(3):425; author reply 425. PubMed ID: 12913224
    [No Abstract] [Full Text] [Related]

  • 20. PC or PCV, That Is the Question: Primary Anaplastic Oligodendroglial Tumors Treated with Procarbazine and CCNU With and Without Vincristine.
    Webre C, Shonka N, Smith L, Liu D, De Groot J.
    Anticancer Res; 2015 Oct 12; 35(10):5467-72. PubMed ID: 26408710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.